共 4 条
Public awareness regarding the manufacturer provided information about medicine usage, safety, and adverse drug reactions in Balochistan, Pakistan
被引:2
|作者:
Khan, Gullab
[1
]
Haq, Noman
[1
]
Ahmad, Nafees
[1
]
Nasim, Aqeel
[2
]
Javaid, Asma
[3
]
Saood, Mujhammad
[2
]
Yasmin, Riffat
[4
]
Tahir, Maria
[5
]
Riaz, Sohail
[6
]
Danish, Zeeshan
[7
]
Razzaq, Ghulam
[1
]
Khan, Abdullah
[8
]
Younis, Muhammad
[1
]
Rabbani, Tahmina
[1
]
机构:
[1] Univ Balochistan, Fac Pharm & Hlth Sci, Quetta, Pakistan
[2] Prov Drug Testing Lab Balochistan, Quetta, Pakistan
[3] Sardar Begum Dent Hosp, Peshawar, Pakistan
[4] Balochistan Inst Nephrol Urol Quetta, Quetta, Pakistan
[5] Sardar Bahadur Khan Womens Univ, Quetta, Pakistan
[6] Capital Univ Sci & Technol, Islamabad, Pakistan
[7] Univ Punjab, Dept Pharm, Lahore, Pakistan
[8] Civil Hosp Quetta, Quetta, Pakistan
关键词:
public awareness;
medicine information;
safety;
Quetta;
Pakistan;
PATIENT KNOWLEDGE;
NATIVE LANGUAGE;
HEALTH LITERACY;
PERCEPTION;
D O I:
10.3389/fphar.2023.1190741
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Objectives: This study aimed to analyze the general public's awareness of medicine information, safety, and adverse drug reactions in Quetta, Pakistan.Methods: A cross-sectional descriptive study was conducted using random sampling from April 2020 to April 2021 in Quetta. Samples were collected from respondents who met the inclusion criteria and had visited community pharmacies. The analysis was done using SPSS version 23. Bivariate and multivariate analyses were performed to assess factors associated with good knowledge.Results: Multivariate analysis revealed that purchase on prescription was a determining factor of knowledge regarding knowledge of pharmaceutical products and their provided information, medicines usage and safety, and Medication ADRs. Patients who bought medicines on prescriptions were more likely to have better knowledge. Patients having education were more likely to have better knowledge.Conclusion: Public awareness about medicine information, safety, and the information provided by manufacturers is crucial to ensuring that patients have access to accurate information about their medications and can make informed decisions about their health. Healthcare providers and regulatory bodies must work together to improve access to information and promote safe medication practices.
引用
收藏
页数:11
相关论文